The reduced GAPDH acetylation was also observed in the liver of obesity and type 2 diabetes mouse models, and key lysine residues in GAPDH contribute to the regulation of glucose tolerance and sensitivity to glucagon and insulin (Bond et al., 2017). The gene discussed is GAPDH; the disease is obesity disorder.